Cook Jennifer E.
Insider CIK 1754371 · JAZZ Director · DNLI Director · BBIO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2026-08-31 | 2026-09-02 | 1,692 | $241.39 | $408.4K | 10,736 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2026-08-31 | 2026-09-02 | 14 | $244.06 | $3.4K | 12,428 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2026-08-31 | 2026-09-02 | 1,692 | $241.39 | $408.4K | 10,736 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2026-08-31 | 2026-09-02 | 14 | $244.06 | $3.4K | 12,428 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2026-08-05 | 2026-08-07 | 1,605 | — | $0 | 12,442 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2026-08-05 | 2026-08-07 | 1,605 | — | $0 | 12,442 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-07-09 | 2026-07-13 | 17,167 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-07-09 | 2026-07-13 | 112,422 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-07-09 | 2026-07-13 | 19,000 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-07-09 | 2026-07-13 | 112,422 | $90.00 | $10.12M | 8,383 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-07-09 | 2026-07-13 | 19,000 | $8.45 | $160.6K | 27,383 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-07-09 | 2026-07-13 | 112,422 | $29.00 | $3.26M | 139,805 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-07-09 | 2026-07-13 | 17,167 | $16.75 | $287.5K | 156,972 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-07-09 | 2026-07-13 | 36,167 | $84.00 | $3.04M | 120,805 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-06-24 | 2026-06-24 | 20,000 | — | $0 | 19,000 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-06-24 | 2026-06-24 | 17,167 | — | $0 | 17,167 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-06-24 | 2026-06-24 | 20,000 | $8.45 | $169.0K | 28,383 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-06-24 | 2026-06-24 | 17,167 | $16.75 | $287.5K | 45,550 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-06-24 | 2026-06-24 | 37,167 | $70.00 | $2.60M | 8,383 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-06-23 | 2026-06-24 | 2,196 | $68.57 | $150.6K | 8,383 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2026-06-22 | 2026-06-24 | 5,277 | — | $0 | 5,277 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award | 2026-06-22 | 2026-06-24 | 3,990 | — | $0 | 10,579 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-06-15 | 2026-06-17 | 65,921 | — | $0 | 39,000 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-06-15 | 2026-06-17 | 17,167 | — | $0 | 34,334 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-06-15 | 2026-06-17 | 88,737 | $66.62 | $5.91M | 8,092 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-06-15 | 2026-06-17 | 17,167 | $16.75 | $287.5K | 96,829 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-06-15 | 2026-06-17 | 65,921 | $8.45 | $557.0K | 79,662 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-06-15 | 2026-06-17 | 1,503 | $67.14 | $100.9K | 6,589 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2026-06-03 | 2026-06-05 | 19,226 | — | $0 | 19,226 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2026-06-03 | 2026-06-05 | 6,408 | — | $0 | 32,483 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2025-08-08 | 2025-08-11 | 1,805 | $111.25 | $200.8K | 10,837 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2025-08-07 | 2025-08-11 | 3,507 | — | $0 | 12,642 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2025-06-20 | 2025-06-24 | 8,425 | — | $0 | 8,425 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award | 2025-06-20 | 2025-06-24 | 6,589 | — | $0 | 13,741 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2025-06-03 | 2025-06-05 | 18,111 | — | $0 | 18,111 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2025-06-03 | 2025-06-05 | 6,037 | — | $0 | 26,075 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2024-08-06 | 2024-08-06 | 1,484 | $111.35 | $165.2K | 9,135 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2024-08-02 | 2024-08-06 | 3,731 | — | $0 | 10,619 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2024-06-21 | 2024-06-25 | 26,014 | — | $0 | 26,014 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2024-06-06 | 2024-06-10 | 1,458 | $21.73 | $31.7K | 20,038 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2024-05-31 | 2024-06-04 | 17,901 | — | $0 | 17,901 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2024-05-31 | 2024-06-04 | 5,967 | — | $0 | 21,496 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2023-12-04 | 2023-12-06 | 417 | $119.27 | $49.7K | 6,888 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2023-08-14 | 2023-08-15 | 1,241 | $138.16 | $171.5K | 7,305 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2023-08-11 | 2023-08-15 | 3,075 | — | $0 | 8,546 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2023-06-21 | 2023-06-23 | 51,501 | — | $0 | 51,501 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 12,649 | — | $0 | 12,649 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2023-06-01 | 2023-06-05 | 4,216 | — | $0 | 15,529 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2022-12-02 | 2022-12-06 | 420 | $154.68 | $65.0K | 5,471 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2022-08-08 | 2022-08-09 | 1,089 | $152.32 | $165.9K | 5,891 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2022-08-05 | 2022-08-09 | 2,561 | — | $0 | 6,980 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 104,921 | — | $0 | 104,921 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 17,959 | — | $0 | 17,959 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2022-06-02 | 2022-06-06 | 5,986 | — | $0 | 11,313 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2021-12-02 | 2021-12-06 | 417 | $121.30 | $50.6K | 4,419 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2021-11-16 | 2023-02-21 | 3,576 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2021-11-16 | 2023-02-21 | 3,576 | — | $0 | 7,152 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2021-07-29 | 2021-08-02 | 2,246 | — | $0 | 4,836 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2021-06-17 | 2021-06-22 | 38,895 | — | $0 | 38,895 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2021-06-02 | 2021-06-04 | 6,222 | — | $0 | 6,222 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2021-06-02 | 2021-06-04 | 2,074 | — | $0 | 5,327 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2021-06-01 | 2021-06-03 | 3,253 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2021-06-01 | 2021-06-03 | 3,253 | — | $0 | 3,253 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2021-02-25 | 2021-03-01 | 6,475 | — | $0 | 6,475 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2021-02-25 | 2021-03-01 | 2,590 | — | $0 | 2,590 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2020-11-16 | 2020-11-18 | 3,576 | — | $0 | 3,576 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2020-11-16 | 2020-11-18 | 3,576 | — | $0 | 3,576 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 15,183 | — | $0 | 15,183 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 3,253 | — | $0 | 3,253 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-06-02 | 2020-06-04 | 112,422 | — | $0 | 112,422 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2019-12-12 | 2019-12-16 | 82,878 | — | $0 | 82,878 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2019-05-30 | 2019-05-31 | 27,245 | — | $0 | 27,245 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2018-11-06 | 2018-11-08 | 50,044 | — | $0 | 50,044 | SEC↗ |